Investor Relations

Data Provided by Refinitiv. Minimum 15 minutes delayed.

 

 

Data Provided by Refinitiv. Minimum 15 minutes delayed.

 

 

Press Releases
12-Aug-20

Number of shares and voting rights of Innate Pharma as at August 1, 2020

Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities ( Autorité des Marchés Financiers , or “AMF”) General Regulation, Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH; Nasdaq: IPHA) releases its total

11-Aug-20

Innate Pharma obtains €6.8M in public funding for its COVID-19 research and development activities

Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“ Innate ” or the “ Company ”) today announced the Company has obtained funding of €6.8M under the PSPC-COVID call for projects to support the Company’s COVID-19 research and development activities.

29-Jul-20

INNATE PHARMA ANNOUNCES PUBLICATION OF EXPLORE COVID-19 TRANSLATIONAL STUDY FINDINGS IN NATURE

New research suggests targeting C5a-C5aR1 axis could limit severe inflammatory response Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“ Innate ” or the “ Company ”) today announced the publication of a Nature paper entitled, “Association of COVID-19 inflammation with